171 related articles for article (PubMed ID: 36823110)
1. A first-in-class POLRMT specific inhibitor IMT1 suppresses endometrial carcinoma cell growth.
Li SP; Ou L; Zhang Y; Shen FR; Chen YG
Cell Death Dis; 2023 Feb; 14(2):152. PubMed ID: 36823110
[TBL] [Abstract][Full Text] [Related]
2. Targeting POLRMT by a first-in-class inhibitor IMT1 inhibits osteosarcoma cell growth in vitro and in vivo.
Kong Y; Li X; Zhang H; Fu B; Jiang HY; Yang HL; Dai J
Cell Death Dis; 2024 Jan; 15(1):57. PubMed ID: 38228583
[TBL] [Abstract][Full Text] [Related]
3. The mitochondrial RNA polymerase POLRMT promotes skin squamous cell carcinoma cell growth.
Wang Y; Ou L; Li X; Zheng T; Zhu WP; Li P; Wu L; Zhao T
Cell Death Discov; 2022 Aug; 8(1):347. PubMed ID: 35922422
[TBL] [Abstract][Full Text] [Related]
4. Identification of the mitochondrial protein POLRMT as a potential therapeutic target of prostate cancer.
Li X; Yao L; Wang T; Gu X; Wu Y; Jiang T
Cell Death Dis; 2023 Oct; 14(10):665. PubMed ID: 37816734
[TBL] [Abstract][Full Text] [Related]
5. The requirement of mitochondrial RNA polymerase for non-small cell lung cancer cell growth.
Zhou T; Sang YH; Cai S; Xu C; Shi MH
Cell Death Dis; 2021 Jul; 12(8):751. PubMed ID: 34326320
[TBL] [Abstract][Full Text] [Related]
6. A first-in-class TIMM44 blocker inhibits bladder cancer cell growth.
Zhang L; Shi X; Zhang L; Mi Y; Zuo L; Gao S
Cell Death Dis; 2024 Mar; 15(3):204. PubMed ID: 38467612
[TBL] [Abstract][Full Text] [Related]
7. Identification of mitochondrial RNA polymerase as a potential therapeutic target of osteosarcoma.
Han QC; Zhang XY; Yan PH; Chen SF; Liu FF; Zhu YR; Tian Q
Cell Death Discov; 2021 Dec; 7(1):393. PubMed ID: 34907167
[TBL] [Abstract][Full Text] [Related]
8. ADCK1 is a potential therapeutic target of osteosarcoma.
Zhuo BB; Zhu LQ; Yao C; Wang XH; Li SX; Wang R; Li Y; Ling ZY
Cell Death Dis; 2022 Nov; 13(11):954. PubMed ID: 36371387
[TBL] [Abstract][Full Text] [Related]
9. The pro-tumorigenic activity of p38γ overexpression in nasopharyngeal carcinoma.
Yin DP; Zheng YF; Sun P; Yao MY; Xie LX; Dou XW; Tian Y; Liu JS
Cell Death Dis; 2022 Mar; 13(3):210. PubMed ID: 35246508
[TBL] [Abstract][Full Text] [Related]
10. POLRMT regulates the switch between replication primer formation and gene expression of mammalian mtDNA.
Kühl I; Miranda M; Posse V; Milenkovic D; Mourier A; Siira SJ; Bonekamp NA; Neumann U; Filipovska A; Polosa PL; Gustafsson CM; Larsson NG
Sci Adv; 2016 Aug; 2(8):e1600963. PubMed ID: 27532055
[TBL] [Abstract][Full Text] [Related]
11. HOXC13-driven TIMM13 overexpression promotes osteosarcoma cell growth.
Han Q; Yan P; Song R; Liu F; Tian Q
Cell Death Dis; 2023 Jul; 14(7):398. PubMed ID: 37407582
[TBL] [Abstract][Full Text] [Related]
12. Targeting Mitochondrial DNA Transcription by POLRMT Inhibition or Depletion as a Potential Strategy for Cancer Treatment.
Daglish SCD; Fennell EMJ; Graves LM
Biomedicines; 2023 May; 11(6):. PubMed ID: 37371693
[TBL] [Abstract][Full Text] [Related]
13. Reversible inhibition of lysine specific demethylase 1 is a novel anti-tumor strategy for poorly differentiated endometrial carcinoma.
Theisen ER; Gajiwala S; Bearss J; Sorna V; Sharma S; Janat-Amsbury M
BMC Cancer; 2014 Oct; 14():752. PubMed ID: 25300887
[TBL] [Abstract][Full Text] [Related]
14. Small-molecule inhibitors of human mitochondrial DNA transcription.
Bonekamp NA; Peter B; Hillen HS; Felser A; Bergbrede T; Choidas A; Horn M; Unger A; Di Lucrezia R; Atanassov I; Li X; Koch U; Menninger S; Boros J; Habenberger P; Giavalisco P; Cramer P; Denzel MS; Nussbaumer P; Klebl B; Falkenberg M; Gustafsson CM; Larsson NG
Nature; 2020 Dec; 588(7839):712-716. PubMed ID: 33328633
[TBL] [Abstract][Full Text] [Related]
15. The antitumor effect of lobaplatin against Ishikawa endometrial cancer cells in vitro and in vivo.
He J; Zhang H
Biomed Pharmacother; 2019 Jun; 114():108762. PubMed ID: 30925454
[TBL] [Abstract][Full Text] [Related]
16. TESTIN suppresses tumor growth and invasion via manipulating cell cycle progression in endometrial carcinoma.
Gu Z; Ding G; Liang K; Zhang H; Guo G; Zhang L; Cui J
Med Sci Monit; 2014 Jun; 20():980-7. PubMed ID: 24929083
[TBL] [Abstract][Full Text] [Related]
17. Lentivirus-mediated RNA interference targeting the long noncoding RNA HOTAIR inhibits proliferation and invasion of endometrial carcinoma cells in vitro and in vivo.
Huang J; Ke P; Guo L; Wang W; Tan H; Liang Y; Yao S
Int J Gynecol Cancer; 2014 May; 24(4):635-42. PubMed ID: 24758900
[TBL] [Abstract][Full Text] [Related]
18. Targeting SphK1/2 by SKI-178 inhibits prostate cancer cell growth.
Jin L; Zhu J; Yao L; Shen G; Xue BX; Tao W
Cell Death Dis; 2023 Aug; 14(8):537. PubMed ID: 37604912
[TBL] [Abstract][Full Text] [Related]
19. [Effects of PD98059 and LY294002 on subcutaneous xenograft of human endometrial carcinoma in nude mice].
Guo RX; Zhang RF; Wang XY; Shi HR; Qiao YH
Zhonghua Fu Chan Ke Za Zhi; 2011 Jun; 46(6):446-52. PubMed ID: 21781587
[TBL] [Abstract][Full Text] [Related]
20. α-Hederin Induces Apoptosis of Esophageal Squamous Cell Carcinoma via an Oxidative and Mitochondrial-Dependent Pathway.
Wang J; Wu D; Zhang J; Liu H; Wu J; Dong W
Dig Dis Sci; 2019 Dec; 64(12):3528-3538. PubMed ID: 31273592
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
